Intra-cellular Therapies, Inc. (ITCI) Earnings
|
Expand Research on ITCI
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +15.1% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +0.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/25  |
Q125 | N/A | -$0.08 | N/A | N/A | $202.04M | N/A | N/A | N/A | ||
| 2/26/25 |
Q424 | N/A | -$0.07 | N/A | N/A | $194.02M | = | N/A | N/A | ||
| 10/30/24 | Q324 | -$0.25 | -$0.18 | -$0.07 | $175.4M | $172.35M | = |  | | Details | |
| 8/7/24 | Q224 | -$0.16 | -$0.19 | +$0.03 | $161.4M | $158.1M | = | | | Details | |
| 5/7/24 | Q124 | -$0.16 | -$0.32 | +$0.16 | $144.84M | $141.21M | = | | | Details | |
| 2/22/24 | Q423 | -$0.30 | -$0.45 | +$0.15 | $132.21M | $136.27M | = | | | Details | |
| 11/2/23 | Q323 | -$0.25 | -$0.56 | +$0.31 | $126.17M | $119.72M | = | | | Details | |
| 8/3/23 | Q223 | -$0.45 | -$0.59 | +$0.14 | $110.8M | $106.54M | = | | | Details |
